Projects per year
Personal profile
Research Strategic Pillar
The Chief Research Officer, has determined that UTMB research should be prioritized into six health communities. This researcher has received the following badge(s):
Research Strategic Pillar Keywords
- Specialized Health
Fingerprint
- 1 Similar Profiles
-
Grant #85400: Inhibition of bacterial and host H2S for antimicrobial defense after burns
Toliver-Kinsky, T. (PI)
Shriners Hospitals for Children - Texas ( Award #85400)
1/1/17 → 8/31/19
Project: Research project
-
TP508 Mitigates Radiotherapy-induced Tissue Damage
Toliver-Kinsky, T. (PI)
Chrysalis BioTechnology ( Award #HHSN261201300076C)
9/20/13 → 9/19/16
Project: Research project
-
ELII: TP508: A New Drug for Mitigating Lethal Effects of Radiation Exposure
Toliver-Kinsky, T. (PI)
Chrysalis BioTechnology ( Award #5R44AI08613506)
10/1/12 → 10/31/17
Project: Research project
-
Current problems in burn immunology
Blears, E., Sommerhalder, C., Toliver-Kinsky, T., Finnerty, C. C. & Herndon, D., Jun 2020, In: Current Problems in Surgery. 57, 6, 100779.Research output: Contribution to journal › Article › peer-review
10 Scopus citations -
Hydrogen sulfide: An endogenous regulator of the immune system
Dilek, N., Papapetropoulos, A., Toliver-Kinsky, T. & Szabo, C., Nov 2020, In: Pharmacological Research. 161, 105119.Research output: Contribution to journal › Review article › peer-review
Open Access187 Scopus citations -
In brief
Blears, E., Sommerhalder, C., Toliver-Kinsky, T., Finnerty, C. C. & Herndon, D. N., Jun 2020, In: Current Problems in Surgery. 57, 6, 100781.Research output: Contribution to journal › Comment/debate › peer-review
-
H 2 S, a bacterial defense mechanism against the host immune response
Toliver-Kinsky, T., Cui, W., Törö, G., Lee, S. J., Shatalin, K., Nudler, E. & Szaboa, C., Jan 1 2019, In: Infection and immunity. 87, 1, e00272.Research output: Contribution to journal › Article › peer-review
Open Access72 Scopus citations -
The PARP inhibitor olaparib exerts beneficial effects in mice subjected to cecal ligature and puncture and in cells subjected to oxidative stress without impairing DNA integrity: A potential opportunity for repurposing a clinically used oncological drug for the experimental therapy of sepsis
Ahmad, A., Vieira, J. D. C., de Mello, A. H., de Lima, T. M., Ariga, S. K., Barbeiro, D. F., Barbeiro, H. V., Szczesny, B., Törö, G., Druzhyna, N., Randi, E. B., Marcatti, M., Toliver-Kinsky, T., Kiss, A., Liaudet, L., Salomao, R., Soriano, F. G. & Szabo, C., Jul 2019, In: Pharmacological Research. 145, 104263.Research output: Contribution to journal › Article › peer-review
Open Access26 Scopus citations